BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 21495062)

  • 21. Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR; Richardson S
    Stat Med; 2012 Feb; 31(4):383-96. PubMed ID: 22253142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What random assignment does and does not do.
    Krause MS; Howard KI
    J Clin Psychol; 2003 Jul; 59(7):751-66. PubMed ID: 12808582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials.
    Ukoumunne OC; Forbes AB; Carlin JB; Gulliford MC
    Stat Med; 2008 Nov; 27(25):5143-55. PubMed ID: 18613226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies.
    Harbord RM; Didelez V; Palmer TM; Meng S; Sterne JA; Sheehan NA
    Stat Med; 2013 Mar; 32(7):1246-58. PubMed ID: 23080538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Time-dependent confounding in the estimation of treatment effects in randomised trials with multimodal therapies--an illustration of the problem of time-dependent confounding by causal graphs].
    Zietemann VD; Schuster T; Duell TH
    Gesundheitswesen; 2015 Jan; 77(1):62-6. PubMed ID: 24203687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence from nonrandomized studies: a case study on the estimation of causal effects.
    Schmoor C; Caputo A; Schumacher M
    Am J Epidemiol; 2008 May; 167(9):1120-9. PubMed ID: 18334500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of propensity scores using generalized additive models.
    Woo MJ; Reiter JP; Karr AF
    Stat Med; 2008 Aug; 27(19):3805-16. PubMed ID: 18366144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instrumental variable estimation of the causal hazard ratio.
    Wang L; Tchetgen Tchetgen E; Martinussen T; Vansteelandt S
    Biometrics; 2023 Jun; 79(2):539-550. PubMed ID: 36377509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study.
    Bender R; Vervölgyi V
    Contemp Clin Trials; 2010 Sep; 31(5):498-505. PubMed ID: 20624484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.
    Hossain MB; Mosquera L; Karim ME
    BMC Med Res Methodol; 2022 Feb; 22(1):46. PubMed ID: 35172746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An introduction to instrumental variables--part 2: Mendelian randomisation.
    Bennett DA
    Neuroepidemiology; 2010; 35(4):307-10. PubMed ID: 21042034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.
    Gao D; Hu J; Bradley CJ; Yang F
    Stat Med; 2023 Oct; 42(24):4349-4376. PubMed ID: 37828812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance.
    Kim MY
    J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
    McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
    BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.